245 related articles for article (PubMed ID: 30086783)
1. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
[TBL] [Abstract][Full Text] [Related]
2. Diffuse myocardial fibrosis and the prognosis of heart failure with reduced ejection fraction in Chinese patients: a cohort study.
Li F; Xu M; Fan Y; Wang Y; Song Y; Cui X; Fu M; Qi B; Han X; Zhou J; Ge J
Int J Cardiovasc Imaging; 2020 Apr; 36(4):671-689. PubMed ID: 31893323
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
4. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
5. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of heart failure in hemodialysis-dependent end-stage renal disease patients with myocardial fibrosis quantification by extracellular volume on cardiac magnetic resonance imaging.
Xu HY; Yang ZG; Zhang Y; Peng WL; Xia CC; Li ZL; He Y; Xu R; Rao L; Peng Y; Li YM; Gao HL; Guo YK
BMC Cardiovasc Disord; 2020 Jan; 20(1):12. PubMed ID: 31924159
[TBL] [Abstract][Full Text] [Related]
7. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome.
Schelbert EB; Fridman Y; Wong TC; Abu Daya H; Piehler KM; Kadakkal A; Miller CA; Ugander M; Maanja M; Kellman P; Shah DJ; Abebe KZ; Simon MA; Quarta G; Senni M; Butler J; Diez J; Redfield MM; Gheorghiade M
JAMA Cardiol; 2017 Sep; 2(9):995-1006. PubMed ID: 28768311
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
[TBL] [Abstract][Full Text] [Related]
9. A Radiomic MRI based Nomogram for Prediction of Heart Failure with Preserved Ejection Fraction in Systemic Lupus Erythematosus Patients: Insights From a Three-Center Prospective Study.
Wu LM; Shi RY; Wu CW; Jiang M; Guo Q; Zhu YS; Tang LL; Xu JR; Pu J; Zhou Y; Wu R
J Magn Reson Imaging; 2022 Sep; 56(3):779-789. PubMed ID: 35049073
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
11. Myocardial fibrosis and prognosis in heart failure with preserved ejection fraction: a pooled analysis of 12 cohort studies.
Zhang X; Yang S; Hao S; Li J; Qiu M; Chen H; Huang Y
Eur Radiol; 2024 Mar; 34(3):1854-1862. PubMed ID: 37658896
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
[TBL] [Abstract][Full Text] [Related]
13. Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure.
Gulati A; Japp AG; Raza S; Halliday BP; Jones DA; Newsome S; Ismail NA; Morarji K; Khwaja J; Spath N; Shakespeare C; Kalra PR; Lloyd G; Mathur A; Cleland JGF; Cowie MR; Assomull RG; Pennell DJ; Ismail TF; Prasad SK
Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007722. PubMed ID: 30354674
[TBL] [Abstract][Full Text] [Related]
14. Serum Albumin Is a Marker of Myocardial Fibrosis, Adverse Pulsatile Aortic Hemodynamics, and Prognosis in Heart Failure With Preserved Ejection Fraction.
Prenner SB; Pillutla R; Yenigalla S; Gaddam S; Lee J; Obeid MJ; Ans AH; Jehangir Q; Kim J; Zamani P; Mazurek JA; Akers SR; Chirinos JA
J Am Heart Assoc; 2020 Feb; 9(3):e014716. PubMed ID: 32009529
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model.
Han P; Zhang R; Wagner S; Xie Y; Cingolani E; Marban E; Christodoulou AG; Li D
J Cardiovasc Magn Reson; 2021 Feb; 23(1):8. PubMed ID: 33568177
[TBL] [Abstract][Full Text] [Related]
16. Relationship between diffuse fibrosis assessed by CMR and depressed myocardial strain in different stages of heart failure.
Zhang Y; Zhang X; Wang Y; Hu X; Wang B; Yang J; Zhao X; Zhang L
Eur J Radiol; 2023 Jul; 164():110848. PubMed ID: 37156180
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of measurement of myocardial extracellular volume using dual-energy CT in heart failure with preserved ejection fraction.
Jiang Y; Ye J; Yang Y; Zhang Y; Yan X; Qiang W; Chen H; Xu S; Zhou L; Qi R; Zhang Q
Sci Rep; 2024 Mar; 14(1):7504. PubMed ID: 38553622
[TBL] [Abstract][Full Text] [Related]
19. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]